nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—hematologic cancer	0.289	1	CbGaD
Mannitol—ABCB1—Lenalidomide—hematologic cancer	0.0626	0.141	CbGbCtD
Mannitol—ABCB1—Daunorubicin—hematologic cancer	0.0367	0.0826	CbGbCtD
Mannitol—ABCB1—Alitretinoin—hematologic cancer	0.0359	0.0809	CbGbCtD
Mannitol—ABCB1—Imatinib—hematologic cancer	0.0281	0.0633	CbGbCtD
Mannitol—ABCB1—Nilotinib—hematologic cancer	0.0255	0.0575	CbGbCtD
Mannitol—ABCB1—Vinorelbine—hematologic cancer	0.0253	0.057	CbGbCtD
Mannitol—ABCB1—Dasatinib—hematologic cancer	0.0226	0.0508	CbGbCtD
Mannitol—ABCB1—Mitoxantrone—hematologic cancer	0.0223	0.0502	CbGbCtD
Mannitol—ABCB1—Betamethasone—hematologic cancer	0.0199	0.0448	CbGbCtD
Mannitol—ABCB1—Gemcitabine—hematologic cancer	0.0197	0.0444	CbGbCtD
Mannitol—ABCB1—Prednisolone—hematologic cancer	0.0196	0.0442	CbGbCtD
Mannitol—ABCB1—Prednisone—hematologic cancer	0.0185	0.0417	CbGbCtD
Mannitol—ABCB1—Irinotecan—hematologic cancer	0.0175	0.0395	CbGbCtD
Mannitol—ABCB1—Vinblastine—hematologic cancer	0.0156	0.0351	CbGbCtD
Mannitol—ABCB1—Vincristine—hematologic cancer	0.0153	0.0346	CbGbCtD
Mannitol—ABCB1—Cisplatin—hematologic cancer	0.0143	0.0322	CbGbCtD
Mannitol—ABCB1—Etoposide—hematologic cancer	0.0141	0.0317	CbGbCtD
Mannitol—ABCB1—Dexamethasone—hematologic cancer	0.0116	0.026	CbGbCtD
Mannitol—ABCB1—Doxorubicin—hematologic cancer	0.00959	0.0216	CbGbCtD
Mannitol—ABCB1—Methotrexate—hematologic cancer	0.00929	0.0209	CbGbCtD
Mannitol—ABCB1—Abacavir transmembrane transport—SLC22A1—hematologic cancer	0.000785	0.0621	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transmembrane transport—ABCG2—hematologic cancer	0.0007	0.0553	CbGpPWpGaD
Mannitol—ABCB1—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.000589	0.0466	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM2—hematologic cancer	0.00058	0.0458	CbGpPWpGaD
Mannitol—ABCB1—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.000554	0.0438	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transport and metabolism—SLC22A1—hematologic cancer	0.000451	0.0356	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYL1—hematologic cancer	0.000439	0.0347	CbGpPWpGaD
Mannitol—ABCB1—Abacavir transport and metabolism—ABCG2—hematologic cancer	0.000402	0.0318	CbGpPWpGaD
Mannitol—ABCB1—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.000322	0.0255	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—NSD1—hematologic cancer	0.000283	0.0224	CbGpPWpGaD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000234	0.0185	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—BCR—hematologic cancer	0.000231	0.0182	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000194	0.0154	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—BNIP3—hematologic cancer	0.00019	0.015	CbGpPWpGaD
Mannitol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000185	0.0146	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000183	0.0145	CbGpPWpGaD
Mannitol—ABCB1—ABC-family proteins mediated transport—ABCC3—hematologic cancer	0.000177	0.014	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—GATA2—hematologic cancer	0.000175	0.0138	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—hematologic cancer	0.000163	0.0129	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—ID2—hematologic cancer	0.000151	0.0119	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PPP1R13L—hematologic cancer	0.000148	0.0117	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000143	0.0113	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—MCL1—hematologic cancer	0.000128	0.0101	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—hematologic cancer	0.000125	0.00991	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000118	0.00931	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CA9—hematologic cancer	0.000117	0.00926	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CXCR5—hematologic cancer	0.000115	0.00908	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—hematologic cancer	0.000113	0.00891	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CXCL13—hematologic cancer	0.000101	0.00802	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—NPM1—hematologic cancer	0.000101	0.00795	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—hematologic cancer	9.67e-05	0.00764	CbGpPWpGaD
Mannitol—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	9.35e-05	0.0074	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—hematologic cancer	9.34e-05	0.00738	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—ABCG2—hematologic cancer	8.88e-05	0.00702	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—FOXP3—hematologic cancer	8.7e-05	0.00688	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—TFRC—hematologic cancer	7.91e-05	0.00626	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—EPO—hematologic cancer	7.62e-05	0.00602	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL13—hematologic cancer	7.45e-05	0.00589	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—GZMB—hematologic cancer	7.45e-05	0.00589	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—hematologic cancer	7.26e-05	0.00574	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—hematologic cancer	7.1e-05	0.00561	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CASP7—hematologic cancer	6.82e-05	0.00539	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—hematologic cancer	6.64e-05	0.00525	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—hematologic cancer	6.61e-05	0.00522	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—PRKCZ—hematologic cancer	6.6e-05	0.00522	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—hematologic cancer	6.54e-05	0.00517	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CD40—hematologic cancer	6.08e-05	0.00481	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—hematologic cancer	5.89e-05	0.00466	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—STAT1—hematologic cancer	5.51e-05	0.00436	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—HLA-DQA1—hematologic cancer	5.27e-05	0.00417	CbGpPWpGaD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—hematologic cancer	5.07e-05	0.00401	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—hematologic cancer	4.88e-05	0.00386	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CD86—hematologic cancer	4.75e-05	0.00376	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—TERT—hematologic cancer	4.74e-05	0.00375	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL10—hematologic cancer	4.66e-05	0.00368	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CD40LG—hematologic cancer	4.66e-05	0.00368	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL4—hematologic cancer	4.53e-05	0.00358	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—PDGFRA—hematologic cancer	4.46e-05	0.00353	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—HLA-B—hematologic cancer	4.43e-05	0.0035	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—JUND—hematologic cancer	4.38e-05	0.00346	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—FASLG—hematologic cancer	4.33e-05	0.00342	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—FAS—hematologic cancer	4.18e-05	0.0033	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL2RA—hematologic cancer	4.15e-05	0.00328	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—hematologic cancer	4.15e-05	0.00328	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—HLA-A—hematologic cancer	4.11e-05	0.00325	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—AQP9—hematologic cancer	4.07e-05	0.00322	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	3.93e-05	0.00311	CbGpPWpGaD
Mannitol—Urinary tract disorder—Epirubicin—hematologic cancer	3.87e-05	0.000152	CcSEcCtD
Mannitol—Rash—Vincristine—hematologic cancer	3.86e-05	0.000152	CcSEcCtD
Mannitol—Dermatitis—Vincristine—hematologic cancer	3.86e-05	0.000152	CcSEcCtD
Mannitol—Pain—Triamcinolone—hematologic cancer	3.85e-05	0.000151	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—hematologic cancer	3.85e-05	0.000151	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—hematologic cancer	3.84e-05	0.000151	CcSEcCtD
Mannitol—Headache—Vincristine—hematologic cancer	3.84e-05	0.000151	CcSEcCtD
Mannitol—Hypotension—Dexamethasone—hematologic cancer	3.82e-05	0.00015	CcSEcCtD
Mannitol—Hypotension—Betamethasone—hematologic cancer	3.82e-05	0.00015	CcSEcCtD
Mannitol—Nausea—Carmustine—hematologic cancer	3.81e-05	0.00015	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	3.81e-05	0.00301	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	3.8e-05	0.00301	CbGpPWpGaD
Mannitol—Vomiting—Mitoxantrone—hematologic cancer	3.79e-05	0.000149	CcSEcCtD
Mannitol—Vomiting—Irinotecan—hematologic cancer	3.79e-05	0.000149	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	3.78e-05	0.00299	CbGpPWpGaD
Mannitol—Nausea—Alitretinoin—hematologic cancer	3.78e-05	0.000148	CcSEcCtD
Mannitol—Convulsion—Prednisone—hematologic cancer	3.78e-05	0.000148	CcSEcCtD
Mannitol—Mediastinal disorder—Methotrexate—hematologic cancer	3.77e-05	0.000148	CcSEcCtD
Mannitol—Hypertension—Prednisone—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Mannitol—Rash—Irinotecan—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Mannitol—Rash—Mitoxantrone—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Mannitol—Dermatitis—Irinotecan—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Mannitol—Dermatitis—Mitoxantrone—hematologic cancer	3.76e-05	0.000148	CcSEcCtD
Mannitol—Chills—Methotrexate—hematologic cancer	3.75e-05	0.000147	CcSEcCtD
Mannitol—Headache—Mitoxantrone—hematologic cancer	3.74e-05	0.000147	CcSEcCtD
Mannitol—Headache—Irinotecan—hematologic cancer	3.74e-05	0.000147	CcSEcCtD
Mannitol—Nausea—Ifosfamide—hematologic cancer	3.73e-05	0.000147	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.72e-05	0.000146	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.72e-05	0.000146	CcSEcCtD
Mannitol—Arthralgia—Prednisone—hematologic cancer	3.71e-05	0.000146	CcSEcCtD
Mannitol—Feeling abnormal—Triamcinolone—hematologic cancer	3.71e-05	0.000146	CcSEcCtD
Mannitol—Diarrhoea—Cisplatin—hematologic cancer	3.71e-05	0.000146	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	3.7e-05	0.00293	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	3.7e-05	0.00292	CbGpPWpGaD
Mannitol—Vomiting—Gemcitabine—hematologic cancer	3.69e-05	0.000145	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.68e-05	0.000145	CcSEcCtD
Mannitol—Discomfort—Prednisone—hematologic cancer	3.67e-05	0.000144	CcSEcCtD
Mannitol—Mental disorder—Methotrexate—hematologic cancer	3.67e-05	0.000144	CcSEcCtD
Mannitol—Rash—Gemcitabine—hematologic cancer	3.66e-05	0.000144	CcSEcCtD
Mannitol—Dermatitis—Gemcitabine—hematologic cancer	3.66e-05	0.000144	CcSEcCtD
Mannitol—Hypersensitivity—Etoposide—hematologic cancer	3.66e-05	0.000144	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	3.64e-05	0.00288	CbGpPWpGaD
Mannitol—Malnutrition—Methotrexate—hematologic cancer	3.64e-05	0.000143	CcSEcCtD
Mannitol—Headache—Gemcitabine—hematologic cancer	3.64e-05	0.000143	CcSEcCtD
Mannitol—Nausea—Vincristine—hematologic cancer	3.64e-05	0.000143	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—hematologic cancer	3.63e-05	0.000143	CcSEcCtD
Mannitol—Hypersensitivity—Prednisolone—hematologic cancer	3.61e-05	0.000142	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—hematologic cancer	3.6e-05	0.000141	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—hematologic cancer	3.58e-05	0.000141	CcSEcCtD
Mannitol—Urticaria—Triamcinolone—hematologic cancer	3.58e-05	0.00014	CcSEcCtD
Mannitol—Asthenia—Etoposide—hematologic cancer	3.56e-05	0.00014	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—hematologic cancer	3.56e-05	0.00014	CcSEcCtD
Mannitol—Body temperature increased—Triamcinolone—hematologic cancer	3.56e-05	0.00014	CcSEcCtD
Mannitol—Oedema—Prednisone—hematologic cancer	3.56e-05	0.00014	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—hematologic cancer	3.55e-05	0.00014	CcSEcCtD
Mannitol—Decreased appetite—Dexamethasone—hematologic cancer	3.55e-05	0.000139	CcSEcCtD
Mannitol—Decreased appetite—Betamethasone—hematologic cancer	3.55e-05	0.000139	CcSEcCtD
Mannitol—Nausea—Mitoxantrone—hematologic cancer	3.54e-05	0.000139	CcSEcCtD
Mannitol—Nausea—Irinotecan—hematologic cancer	3.54e-05	0.000139	CcSEcCtD
Mannitol—Infection—Prednisone—hematologic cancer	3.53e-05	0.000139	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—hematologic cancer	3.53e-05	0.000139	CcSEcCtD
Mannitol—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.53e-05	0.000139	CcSEcCtD
Mannitol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.53e-05	0.000139	CcSEcCtD
Mannitol—Back pain—Methotrexate—hematologic cancer	3.52e-05	0.000138	CcSEcCtD
Mannitol—Fatigue—Dexamethasone—hematologic cancer	3.52e-05	0.000138	CcSEcCtD
Mannitol—Fatigue—Betamethasone—hematologic cancer	3.52e-05	0.000138	CcSEcCtD
Mannitol—Chills—Epirubicin—hematologic cancer	3.51e-05	0.000138	CcSEcCtD
Mannitol—Pruritus—Etoposide—hematologic cancer	3.51e-05	0.000138	CcSEcCtD
Mannitol—Pain—Dexamethasone—hematologic cancer	3.49e-05	0.000137	CcSEcCtD
Mannitol—Pain—Betamethasone—hematologic cancer	3.49e-05	0.000137	CcSEcCtD
Mannitol—Nervous system disorder—Prednisone—hematologic cancer	3.49e-05	0.000137	CcSEcCtD
Mannitol—Tachycardia—Prednisone—hematologic cancer	3.47e-05	0.000136	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CD80—hematologic cancer	3.47e-05	0.00274	CbGpPWpGaD
Mannitol—Skin disorder—Prednisone—hematologic cancer	3.45e-05	0.000136	CcSEcCtD
Mannitol—Nausea—Gemcitabine—hematologic cancer	3.45e-05	0.000136	CcSEcCtD
Mannitol—Vomiting—Cisplatin—hematologic cancer	3.44e-05	0.000135	CcSEcCtD
Mannitol—Vision blurred—Methotrexate—hematologic cancer	3.43e-05	0.000135	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—hematologic cancer	3.43e-05	0.000135	CcSEcCtD
Mannitol—Rash—Cisplatin—hematologic cancer	3.42e-05	0.000134	CcSEcCtD
Mannitol—Dermatitis—Cisplatin—hematologic cancer	3.41e-05	0.000134	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—hematologic cancer	3.41e-05	0.000134	CcSEcCtD
Mannitol—Diarrhoea—Etoposide—hematologic cancer	3.4e-05	0.000133	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	3.38e-05	0.00267	CbGpPWpGaD
Mannitol—Ill-defined disorder—Methotrexate—hematologic cancer	3.38e-05	0.000133	CcSEcCtD
Mannitol—Feeling abnormal—Betamethasone—hematologic cancer	3.37e-05	0.000132	CcSEcCtD
Mannitol—Feeling abnormal—Dexamethasone—hematologic cancer	3.37e-05	0.000132	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	3.37e-05	0.00266	CbGpPWpGaD
Mannitol—Flatulence—Epirubicin—hematologic cancer	3.36e-05	0.000132	CcSEcCtD
Mannitol—Hypersensitivity—Triamcinolone—hematologic cancer	3.32e-05	0.00013	CcSEcCtD
Mannitol—Nervousness—Epirubicin—hematologic cancer	3.31e-05	0.00013	CcSEcCtD
Mannitol—Back pain—Epirubicin—hematologic cancer	3.3e-05	0.00013	CcSEcCtD
Mannitol—Malaise—Methotrexate—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Mannitol—Dizziness—Etoposide—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Mannitol—Vertigo—Methotrexate—hematologic cancer	3.27e-05	0.000129	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—hematologic cancer	3.26e-05	0.000128	CcSEcCtD
Mannitol—Chills—Doxorubicin—hematologic cancer	3.25e-05	0.000128	CcSEcCtD
Mannitol—Urticaria—Dexamethasone—hematologic cancer	3.24e-05	0.000127	CcSEcCtD
Mannitol—Urticaria—Betamethasone—hematologic cancer	3.24e-05	0.000127	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.24e-05	0.000127	CcSEcCtD
Mannitol—Dizziness—Prednisolone—hematologic cancer	3.24e-05	0.000127	CcSEcCtD
Mannitol—Asthenia—Triamcinolone—hematologic cancer	3.23e-05	0.000127	CcSEcCtD
Mannitol—Body temperature increased—Betamethasone—hematologic cancer	3.23e-05	0.000127	CcSEcCtD
Mannitol—Body temperature increased—Dexamethasone—hematologic cancer	3.23e-05	0.000127	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—CASP8—hematologic cancer	3.22e-05	0.00255	CbGpPWpGaD
Mannitol—Nausea—Cisplatin—hematologic cancer	3.22e-05	0.000126	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—hematologic cancer	3.21e-05	0.000126	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	3.21e-05	0.00254	CbGpPWpGaD
Mannitol—Pruritus—Triamcinolone—hematologic cancer	3.18e-05	0.000125	CcSEcCtD
Mannitol—Cough—Methotrexate—hematologic cancer	3.18e-05	0.000125	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—hematologic cancer	3.17e-05	0.000125	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—hematologic cancer	3.16e-05	0.000124	CcSEcCtD
Mannitol—Convulsion—Methotrexate—hematologic cancer	3.16e-05	0.000124	CcSEcCtD
Mannitol—Vomiting—Etoposide—hematologic cancer	3.16e-05	0.000124	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—hematologic cancer	3.15e-05	0.000124	CcSEcCtD
Mannitol—Rash—Etoposide—hematologic cancer	3.13e-05	0.000123	CcSEcCtD
Mannitol—Dermatitis—Etoposide—hematologic cancer	3.13e-05	0.000123	CcSEcCtD
Mannitol—Headache—Etoposide—hematologic cancer	3.11e-05	0.000122	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—hematologic cancer	3.11e-05	0.000122	CcSEcCtD
Mannitol—Arthralgia—Methotrexate—hematologic cancer	3.1e-05	0.000122	CcSEcCtD
Mannitol—Chest pain—Methotrexate—hematologic cancer	3.1e-05	0.000122	CcSEcCtD
Mannitol—Decreased appetite—Prednisone—hematologic cancer	3.09e-05	0.000121	CcSEcCtD
Mannitol—Rash—Prednisolone—hematologic cancer	3.09e-05	0.000121	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.08e-05	0.00244	CbGpPWpGaD
Mannitol—Dermatitis—Prednisolone—hematologic cancer	3.08e-05	0.000121	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.08e-05	0.000121	CcSEcCtD
Mannitol—Malaise—Epirubicin—hematologic cancer	3.07e-05	0.000121	CcSEcCtD
Mannitol—Fatigue—Prednisone—hematologic cancer	3.07e-05	0.00012	CcSEcCtD
Mannitol—Headache—Prednisolone—hematologic cancer	3.07e-05	0.00012	CcSEcCtD
Mannitol—Discomfort—Methotrexate—hematologic cancer	3.06e-05	0.00012	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—hematologic cancer	3.06e-05	0.00012	CcSEcCtD
Mannitol—Vertigo—Epirubicin—hematologic cancer	3.06e-05	0.00012	CcSEcCtD
Mannitol—Back pain—Doxorubicin—hematologic cancer	3.05e-05	0.00012	CcSEcCtD
Mannitol—Dizziness—Triamcinolone—hematologic cancer	2.98e-05	0.000117	CcSEcCtD
Mannitol—Cough—Epirubicin—hematologic cancer	2.97e-05	0.000117	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—hematologic cancer	2.97e-05	0.000117	CcSEcCtD
Mannitol—Convulsion—Epirubicin—hematologic cancer	2.95e-05	0.000116	CcSEcCtD
Mannitol—Infection—Methotrexate—hematologic cancer	2.95e-05	0.000116	CcSEcCtD
Mannitol—Nausea—Etoposide—hematologic cancer	2.95e-05	0.000116	CcSEcCtD
Mannitol—Hypertension—Epirubicin—hematologic cancer	2.94e-05	0.000116	CcSEcCtD
Mannitol—Feeling abnormal—Prednisone—hematologic cancer	2.93e-05	0.000115	CcSEcCtD
Mannitol—Asthenia—Dexamethasone—hematologic cancer	2.93e-05	0.000115	CcSEcCtD
Mannitol—Asthenia—Betamethasone—hematologic cancer	2.93e-05	0.000115	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—hematologic cancer	2.93e-05	0.000115	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	2.92e-05	0.00231	CbGpPWpGaD
Mannitol—Nervous system disorder—Methotrexate—hematologic cancer	2.91e-05	0.000115	CcSEcCtD
Mannitol—Nausea—Prednisolone—hematologic cancer	2.91e-05	0.000114	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—hematologic cancer	2.9e-05	0.000114	CcSEcCtD
Mannitol—Chest pain—Epirubicin—hematologic cancer	2.9e-05	0.000114	CcSEcCtD
Mannitol—Pruritus—Betamethasone—hematologic cancer	2.89e-05	0.000114	CcSEcCtD
Mannitol—Pruritus—Dexamethasone—hematologic cancer	2.89e-05	0.000114	CcSEcCtD
Mannitol—Skin disorder—Methotrexate—hematologic cancer	2.89e-05	0.000113	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.88e-05	0.000113	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	2.87e-05	0.00227	CbGpPWpGaD
Mannitol—Discomfort—Epirubicin—hematologic cancer	2.87e-05	0.000113	CcSEcCtD
Mannitol—Vomiting—Triamcinolone—hematologic cancer	2.86e-05	0.000112	CcSEcCtD
Mannitol—Malaise—Doxorubicin—hematologic cancer	2.84e-05	0.000112	CcSEcCtD
Mannitol—Rash—Triamcinolone—hematologic cancer	2.84e-05	0.000111	CcSEcCtD
Mannitol—Dermatitis—Triamcinolone—hematologic cancer	2.84e-05	0.000111	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—hematologic cancer	2.83e-05	0.000111	CcSEcCtD
Mannitol—Urticaria—Prednisone—hematologic cancer	2.83e-05	0.000111	CcSEcCtD
Mannitol—Headache—Triamcinolone—hematologic cancer	2.82e-05	0.000111	CcSEcCtD
Mannitol—Body temperature increased—Prednisone—hematologic cancer	2.81e-05	0.00011	CcSEcCtD
Mannitol—Diarrhoea—Dexamethasone—hematologic cancer	2.79e-05	0.00011	CcSEcCtD
Mannitol—Diarrhoea—Betamethasone—hematologic cancer	2.79e-05	0.00011	CcSEcCtD
Mannitol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	2.79e-05	0.00221	CbGpPWpGaD
Mannitol—Oedema—Epirubicin—hematologic cancer	2.78e-05	0.000109	CcSEcCtD
Mannitol—Hypotension—Methotrexate—hematologic cancer	2.78e-05	0.000109	CcSEcCtD
Mannitol—Infection—Epirubicin—hematologic cancer	2.76e-05	0.000109	CcSEcCtD
Mannitol—Cough—Doxorubicin—hematologic cancer	2.75e-05	0.000108	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—IFNG—hematologic cancer	2.74e-05	0.00217	CbGpPWpGaD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	2.73e-05	0.00216	CbGpPWpGaD
Mannitol—Convulsion—Doxorubicin—hematologic cancer	2.73e-05	0.000107	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—hematologic cancer	2.73e-05	0.000107	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—hematologic cancer	2.72e-05	0.000107	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	2.72e-05	0.00215	CbGpPWpGaD
Mannitol—Tachycardia—Epirubicin—hematologic cancer	2.71e-05	0.000107	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.71e-05	0.000106	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Mannitol—Dizziness—Betamethasone—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Mannitol—Dizziness—Dexamethasone—hematologic cancer	2.7e-05	0.000106	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	2.7e-05	0.00213	CbGpPWpGaD
Mannitol—Arthralgia—Doxorubicin—hematologic cancer	2.68e-05	0.000105	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—hematologic cancer	2.68e-05	0.000105	CcSEcCtD
Mannitol—Nausea—Triamcinolone—hematologic cancer	2.67e-05	0.000105	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.67e-05	0.000105	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—hematologic cancer	2.65e-05	0.000104	CcSEcCtD
Mannitol—Dyspnoea—Methotrexate—hematologic cancer	2.65e-05	0.000104	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	2.63e-05	0.00208	CbGpPWpGaD
Mannitol—Hypersensitivity—Prednisone—hematologic cancer	2.62e-05	0.000103	CcSEcCtD
Mannitol—Hypotension—Epirubicin—hematologic cancer	2.6e-05	0.000102	CcSEcCtD
Mannitol—Vomiting—Dexamethasone—hematologic cancer	2.6e-05	0.000102	CcSEcCtD
Mannitol—Vomiting—Betamethasone—hematologic cancer	2.6e-05	0.000102	CcSEcCtD
Mannitol—Decreased appetite—Methotrexate—hematologic cancer	2.58e-05	0.000102	CcSEcCtD
Mannitol—Rash—Dexamethasone—hematologic cancer	2.58e-05	0.000101	CcSEcCtD
Mannitol—Rash—Betamethasone—hematologic cancer	2.58e-05	0.000101	CcSEcCtD
Mannitol—Oedema—Doxorubicin—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Mannitol—Dermatitis—Betamethasone—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Mannitol—Dermatitis—Dexamethasone—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Mannitol—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.57e-05	0.000101	CcSEcCtD
Mannitol—Fatigue—Methotrexate—hematologic cancer	2.56e-05	0.000101	CcSEcCtD
Mannitol—Headache—Dexamethasone—hematologic cancer	2.56e-05	0.000101	CcSEcCtD
Mannitol—Headache—Betamethasone—hematologic cancer	2.56e-05	0.000101	CcSEcCtD
Mannitol—Infection—Doxorubicin—hematologic cancer	2.56e-05	0.0001	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	2.56e-05	0.00202	CbGpPWpGaD
Mannitol—Asthenia—Prednisone—hematologic cancer	2.55e-05	0.0001	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	2.54e-05	0.00201	CbGpPWpGaD
Mannitol—Pain—Methotrexate—hematologic cancer	2.54e-05	9.99e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	2.54e-05	0.00201	CbGpPWpGaD
Mannitol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.53e-05	9.96e-05	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—hematologic cancer	2.52e-05	9.92e-05	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	2.52e-05	0.00199	CbGpPWpGaD
Mannitol—Pruritus—Prednisone—hematologic cancer	2.52e-05	9.88e-05	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—hematologic cancer	2.51e-05	9.87e-05	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—hematologic cancer	2.5e-05	9.82e-05	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—hematologic cancer	2.48e-05	9.74e-05	CcSEcCtD
Mannitol—Feeling abnormal—Methotrexate—hematologic cancer	2.45e-05	9.62e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	2.45e-05	0.00193	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	2.45e-05	0.00193	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL1B—hematologic cancer	2.44e-05	0.00193	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—CASP3—hematologic cancer	2.44e-05	0.00193	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—IL2—hematologic cancer	2.43e-05	0.00192	CbGpPWpGaD
Mannitol—Diarrhoea—Prednisone—hematologic cancer	2.43e-05	9.56e-05	CcSEcCtD
Mannitol—Nausea—Betamethasone—hematologic cancer	2.43e-05	9.53e-05	CcSEcCtD
Mannitol—Nausea—Dexamethasone—hematologic cancer	2.43e-05	9.53e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	2.42e-05	0.00192	CbGpPWpGaD
Mannitol—Decreased appetite—Epirubicin—hematologic cancer	2.42e-05	9.5e-05	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—hematologic cancer	2.41e-05	9.45e-05	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.4e-05	9.43e-05	CcSEcCtD
Mannitol—Fatigue—Epirubicin—hematologic cancer	2.4e-05	9.42e-05	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	2.39e-05	0.00189	CbGpPWpGaD
Mannitol—Pain—Epirubicin—hematologic cancer	2.38e-05	9.34e-05	CcSEcCtD
Mannitol—Urticaria—Methotrexate—hematologic cancer	2.36e-05	9.28e-05	CcSEcCtD
Mannitol—Dizziness—Prednisone—hematologic cancer	2.35e-05	9.24e-05	CcSEcCtD
Mannitol—Body temperature increased—Methotrexate—hematologic cancer	2.35e-05	9.23e-05	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.34e-05	9.21e-05	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	2.34e-05	0.00185	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	2.34e-05	0.00185	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	2.34e-05	0.00185	CbGpPWpGaD
Mannitol—Dyspnoea—Doxorubicin—hematologic cancer	2.29e-05	9.01e-05	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—hematologic cancer	2.29e-05	9e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.27e-05	0.0018	CbGpPWpGaD
Mannitol—Vomiting—Prednisone—hematologic cancer	2.26e-05	8.88e-05	CcSEcCtD
Mannitol—Rash—Prednisone—hematologic cancer	2.24e-05	8.81e-05	CcSEcCtD
Mannitol—Dermatitis—Prednisone—hematologic cancer	2.24e-05	8.8e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.24e-05	0.00177	CbGpPWpGaD
Mannitol—Decreased appetite—Doxorubicin—hematologic cancer	2.24e-05	8.79e-05	CcSEcCtD
Mannitol—Headache—Prednisone—hematologic cancer	2.23e-05	8.75e-05	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.22e-05	8.73e-05	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—hematologic cancer	2.22e-05	8.72e-05	CcSEcCtD
Mannitol—Urticaria—Epirubicin—hematologic cancer	2.21e-05	8.68e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.2e-05	0.00174	CbGpPWpGaD
Mannitol—Pain—Doxorubicin—hematologic cancer	2.2e-05	8.65e-05	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—hematologic cancer	2.2e-05	8.64e-05	CcSEcCtD
Mannitol—Hypersensitivity—Methotrexate—hematologic cancer	2.19e-05	8.6e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.14e-05	0.00169	CbGpPWpGaD
Mannitol—Asthenia—Methotrexate—hematologic cancer	2.13e-05	8.38e-05	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—hematologic cancer	2.12e-05	8.33e-05	CcSEcCtD
Mannitol—Nausea—Prednisone—hematologic cancer	2.11e-05	8.3e-05	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.11e-05	0.00166	CbGpPWpGaD
Mannitol—Pruritus—Methotrexate—hematologic cancer	2.1e-05	8.26e-05	CcSEcCtD
Mannitol—ABCB1—Metabolism—GMPS—hematologic cancer	2.08e-05	0.00165	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PHYH—hematologic cancer	2.08e-05	0.00165	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—FTCD—hematologic cancer	2.08e-05	0.00165	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.07e-05	0.00164	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.06e-05	0.00163	CbGpPWpGaD
Mannitol—Hypersensitivity—Epirubicin—hematologic cancer	2.05e-05	8.05e-05	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—hematologic cancer	2.04e-05	8.03e-05	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—hematologic cancer	2.03e-05	7.99e-05	CcSEcCtD
Mannitol—Diarrhoea—Methotrexate—hematologic cancer	2.03e-05	7.99e-05	CcSEcCtD
Mannitol—Asthenia—Epirubicin—hematologic cancer	2e-05	7.84e-05	CcSEcCtD
Mannitol—Pruritus—Epirubicin—hematologic cancer	1.97e-05	7.73e-05	CcSEcCtD
Mannitol—Dizziness—Methotrexate—hematologic cancer	1.97e-05	7.72e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	1.92e-05	0.00152	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SMPD3—hematologic cancer	1.91e-05	0.00151	CbGpPWpGaD
Mannitol—Diarrhoea—Epirubicin—hematologic cancer	1.9e-05	7.48e-05	CcSEcCtD
Mannitol—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	1.9e-05	0.0015	CbGpPWpGaD
Mannitol—Hypersensitivity—Doxorubicin—hematologic cancer	1.9e-05	7.45e-05	CcSEcCtD
Mannitol—Vomiting—Methotrexate—hematologic cancer	1.89e-05	7.42e-05	CcSEcCtD
Mannitol—Rash—Methotrexate—hematologic cancer	1.87e-05	7.36e-05	CcSEcCtD
Mannitol—Dermatitis—Methotrexate—hematologic cancer	1.87e-05	7.36e-05	CcSEcCtD
Mannitol—Headache—Methotrexate—hematologic cancer	1.86e-05	7.31e-05	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	1.85e-05	0.00146	CbGpPWpGaD
Mannitol—Asthenia—Doxorubicin—hematologic cancer	1.85e-05	7.25e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	1.84e-05	0.00146	CbGpPWpGaD
Mannitol—Dizziness—Epirubicin—hematologic cancer	1.84e-05	7.23e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	1.82e-05	0.00144	CbGpPWpGaD
Mannitol—Pruritus—Doxorubicin—hematologic cancer	1.82e-05	7.15e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	1.81e-05	0.00143	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	1.81e-05	0.00143	CbGpPWpGaD
Mannitol—ABCB1—Allograft Rejection—TNF—hematologic cancer	1.77e-05	0.0014	CbGpPWpGaD
Mannitol—Vomiting—Epirubicin—hematologic cancer	1.77e-05	6.95e-05	CcSEcCtD
Mannitol—Nausea—Methotrexate—hematologic cancer	1.77e-05	6.94e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	1.76e-05	0.00139	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	1.76e-05	0.00139	CbGpPWpGaD
Mannitol—Diarrhoea—Doxorubicin—hematologic cancer	1.76e-05	6.92e-05	CcSEcCtD
Mannitol—Rash—Epirubicin—hematologic cancer	1.75e-05	6.89e-05	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—hematologic cancer	1.75e-05	6.88e-05	CcSEcCtD
Mannitol—Headache—Epirubicin—hematologic cancer	1.74e-05	6.85e-05	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—hematologic cancer	1.7e-05	6.69e-05	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	1.69e-05	0.00134	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—DCK—hematologic cancer	1.67e-05	0.00132	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—B3GAT1—hematologic cancer	1.67e-05	0.00132	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ASNS—hematologic cancer	1.67e-05	0.00132	CbGpPWpGaD
Mannitol—Nausea—Epirubicin—hematologic cancer	1.65e-05	6.49e-05	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—hematologic cancer	1.64e-05	6.43e-05	CcSEcCtD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	1.62e-05	0.00128	CbGpPWpGaD
Mannitol—Rash—Doxorubicin—hematologic cancer	1.62e-05	6.37e-05	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—hematologic cancer	1.62e-05	6.37e-05	CcSEcCtD
Mannitol—Headache—Doxorubicin—hematologic cancer	1.61e-05	6.33e-05	CcSEcCtD
Mannitol—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	1.6e-05	0.00126	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	1.59e-05	0.00126	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	1.58e-05	0.00125	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HDC—hematologic cancer	1.58e-05	0.00125	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	1.55e-05	0.00122	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.54e-05	0.00122	CbGpPWpGaD
Mannitol—Nausea—Doxorubicin—hematologic cancer	1.53e-05	6.01e-05	CcSEcCtD
Mannitol—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.52e-05	0.00121	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.51e-05	0.00119	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.51e-05	0.00119	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CDA—hematologic cancer	1.44e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.44e-05	0.00114	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PC—hematologic cancer	1.39e-05	0.0011	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.36e-05	0.00108	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.34e-05	0.00106	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.34e-05	0.00106	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GBA—hematologic cancer	1.34e-05	0.00106	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.34e-05	0.00106	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTAP—hematologic cancer	1.23e-05	0.000972	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.23e-05	0.000971	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.2e-05	0.000951	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.17e-05	0.000926	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.17e-05	0.000924	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.13e-05	0.000896	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.13e-05	0.000894	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.13e-05	0.000891	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.11e-05	0.000874	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—FHL2—hematologic cancer	1.1e-05	0.000866	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.08e-05	0.000852	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AGRN—hematologic cancer	1.07e-05	0.000849	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.05e-05	0.000829	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.02e-05	0.000807	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—IDH2—hematologic cancer	1.02e-05	0.000805	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HMMR—hematologic cancer	1.02e-05	0.000805	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.66e-06	0.000764	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ARNTL—hematologic cancer	9.57e-06	0.000757	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.39e-06	0.000743	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	9.37e-06	0.000741	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ACP5—hematologic cancer	9.31e-06	0.000736	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CA9—hematologic cancer	9.31e-06	0.000736	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOR2—hematologic cancer	9.19e-06	0.000727	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—IDH1—hematologic cancer	8.75e-06	0.000692	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.75e-06	0.000692	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.68e-06	0.000686	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTO1—hematologic cancer	8.66e-06	0.000685	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ABCC3—hematologic cancer	8.66e-06	0.000685	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—TXN—hematologic cancer	8.66e-06	0.000685	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SPHK1—hematologic cancer	8.47e-06	0.00067	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.14e-06	0.000644	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.97e-06	0.000631	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SLC22A1—hematologic cancer	7.92e-06	0.000626	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CRABP1—hematologic cancer	7.92e-06	0.000626	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALOX5—hematologic cancer	7.72e-06	0.00061	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.71e-06	0.00061	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NUP98—hematologic cancer	7.47e-06	0.000591	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ADCY7—hematologic cancer	7.25e-06	0.000574	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOA3—hematologic cancer	7.25e-06	0.000574	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NUP214—hematologic cancer	7.2e-06	0.00057	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ABCG2—hematologic cancer	7.06e-06	0.000558	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTR—hematologic cancer	7.06e-06	0.000558	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ENO2—hematologic cancer	6.92e-06	0.000547	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTT1—hematologic cancer	6.71e-06	0.000531	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—SDC1—hematologic cancer	6.56e-06	0.000519	CbGpPWpGaD
Mannitol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.51e-06	0.000515	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.28e-06	0.000497	CbGpPWpGaD
Mannitol—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	5.88e-06	0.000465	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NQO1—hematologic cancer	5.58e-06	0.000441	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CD44—hematologic cancer	5.58e-06	0.000441	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CYCS—hematologic cancer	5.28e-06	0.000417	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.24e-06	0.000415	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTP1—hematologic cancer	4.65e-06	0.000368	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—GSTM1—hematologic cancer	4.28e-06	0.000338	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—NCOR1—hematologic cancer	4.28e-06	0.000338	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—MTHFR—hematologic cancer	3.78e-06	0.000299	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.17e-06	0.000251	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—CREBBP—hematologic cancer	2.94e-06	0.000233	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.79e-06	0.000221	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—ALB—hematologic cancer	2.75e-06	0.000218	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.64e-06	0.000208	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.43e-06	0.000192	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PTEN—hematologic cancer	2.1e-06	0.000166	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—EP300—hematologic cancer	2e-06	0.000159	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.48e-06	0.000117	CbGpPWpGaD
Mannitol—ABCB1—Metabolism—AKT1—hematologic cancer	1.21e-06	9.58e-05	CbGpPWpGaD
